Prostatic stromal tumour of uncertain malignant potential
Jump to navigation
Jump to search
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Prostatic stromal tumour of uncertain malignant potential | |
---|---|
Diagnosis in short | |
Prostatic stromal tumour of uncertain malignant potential. (WC/George Netto) | |
| |
Synonyms | prostatic stromal proliferation of uncertain malignant potential |
| |
LM | increased stromal cellularity, +/-nuclear atypia, +/-benign glands, lack small round blood vessels, no necrosis, no or minimal mitotic activity |
LM DDx | prostatic stromal sarcoma, stromal nodule in benign prostatic hyperplasia, leiomyosarcoma, rhabdomyosarcoma, sarcomatoid prostate carcinoma |
IHC | CD34 +ve, ER +ve, PR +ve, vimentin +ve, panker -ve[citation needed] |
Site | prostate gland |
| |
Clinical history | 20s-80s - typically 50s and 60s |
Prevalence | very rare |
Prognosis | usually good |
Clin. DDx | other tumours of the prostate, benign prostate, BPH |
Prostatic stromal tumour of uncertain malignant potential, abbreviated PSTUMP, is a rare lesion of the prostatic stroma which cannot be definitively classified as benign or malignant.
It may be abbreviated as STUMP;[1] an abbreviation used for a uterine lesion of uncertain malignant potential.
It is also known as prostatic stromal proliferation of uncertain malignant potential (abbreviated PSPUMP).[2]
General
- Rare.
- Typically a good prognosis; however, there are some reports of progression to prostatic stromal sarcoma.[3]
- Wide age range (20s-80s) - but usually 50s and 60s.
Microscopic
Features:
- Overgrowth of spindle cells - "hypercellular stroma" - key feature.[1]
- +/-Atypical nuclei.[1]
- +/-Multinucleation.
- Lack prominent vessels - distinguishes from stromal nodule in BPH.[3]
Note:
- Do not have necrosis and no or minimal mitotic activity - important.[1]
- May be seen with glandular abnormalities.[4]
DDx:
- Stromal proliferation in benign prostatic hyperplasia.
- Prostatic stromal sarcoma.[1]
- Leiomyosarcoma.
- Rhabdomyosarcoma.
- Sarcomatoid prostate carcinoma - often associated with conventional prostate carcinoma & history of radiation.
Subclassification
May be subclassified as per Gaudin et al.:[2]
- Scattered atypical cells with benign glands.
- Minimal atypical cells.
- Leaf like growth pattern (phyllodes-like).
- Atypical cells without glands.
Images
www
IHC
Features:[1]
- ER +ve.
- PR +ve.
- Desmin +ve/-ve.
- CD34 +ve.
See also
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 De Berardinis, E.; Busetto, GM.; Antonini, G.; Giovannone, R.; Di Placido, M.; Magliocca, FM.; Di Silverio, A.; Gentile, V. (2012). "Incidental prostatic stromal tumor of uncertain malignant potential (STUMP): histopathological and immunohistochemical findings.". Urologia 79 (1): 65-8. doi:10.5301/RU.2012.9099. PMID 22388992.
- ↑ 2.0 2.1 Gaudin, PB.; Rosai, J.; Epstein, JI. (Feb 1998). "Sarcomas and related proliferative lesions of specialized prostatic stroma: a clinicopathologic study of 22 cases.". Am J Surg Pathol 22 (2): 148-62. PMID 9500215.
- ↑ 3.0 3.1 Hansel, DE.; Herawi, M.; Montgomery, E.; Epstein, JI. (Jan 2007). "Spindle cell lesions of the adult prostate.". Mod Pathol 20 (1): 148-58. doi:10.1038/modpathol.3800676. PMID 17170745.
- ↑ Nagar, M.; Epstein, JI. (Jun 2011). "Epithelial proliferations in prostatic stromal tumors of uncertain malignant potential (STUMP).". Am J Surg Pathol 35 (6): 898-903. doi:10.1097/PAS.0b013e318214f2f2. PMID 21572264.
- ↑ Murer, LM.; Talmon, GA. (Nov 2014). "Stromal tumor of uncertain malignant potential of the prostate.". Arch Pathol Lab Med 138 (11): 1542-5. doi:10.5858/arpa.2013-0212-RS. PMID 25357117.